search
Back to results

Threat Interpretation Bias as Cognitive Marker and Treatment Target in Pediatric Anxiety

Primary Purpose

Anxiety Disorders

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Cognitive Bias Modification for Interpretations (CBM-I)
Interpretation Control Condition (ICC)
Sponsored by
University of Denver
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Anxiety Disorders focused on measuring Child, Adolescent, Pediatric, Youth, Anxiety, Separation anxiety, Social phobia, Social anxiety, Generalized anxiety, Interpretation bias, Cognitive bias, Cognitive bias modification, Interpretation bias modification, Randomized controlled trial, Threat bias, Threat interpretation, Intervention, Randomized, Cognitive training, National Institute of Mental Health, Personalized

Eligibility Criteria

10 Years - 17 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • youth aged 10 to 17
  • diagnosed at study baseline with a primary "big three" anxiety disorder (Separation, Social, Generalized)
  • standard score greater than or equal to 85 on the Wide Range Achievement Test - Word Reading Subtest (to ensure ability to read stimuli during interpretation bias assessment and CBM-I/ICC), and estimated IQ standard score of at least 80 on the Wechsler Abbreviated Scale of Intelligence
  • youth and consenting parent/legal guardian speak sufficient English to complete consent/assent and study procedures
  • no concurrent psychosocial services during study participation to reduce likelihood that other interventions are responsible for change in primary or secondary outcomes
  • no psychotropic medications with no plans to start medications during study, or six weeks stable on SSRI or psychostimulant medication and dose with no plans to change medication/dose during study

Exclusion Criteria:

  • severe anxiety indicting that youth requires higher level of care (e.g., intensive treatment such as psychiatric hospitalization), significant diagnostic comorbidity (e.g., presence of psychosis or significant mood disorder), or another primary diagnosis that warrants alternate intervention
  • significant uncorrected vision impairment (e.g., uncorrected blindness) that precludes participation in CBM-I/ICC
  • safety concerns due to recent or acute suicidality with plan, intent, and/or attempt that warrants alternate intervention

Sites / Locations

  • BRAVE Lab, Department of Psychology, University of Denver

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Cognitive Bias Modification for Interpretations (CBM-I)

Interpretation Control Condition (ICC)

Arm Description

Computerized 16-session intervention aimed at reducing interpretation bias. In this study, CBM-I is personalized to youth anxiety symptoms. During CBM-I sessions, youth indicate whether word-sentence pairs are related, and are provided with feedback aimed to reduce bias.

Computerized 16-session intervention that is not believed to significantly modify bias. In this study, youth see stimuli personalized to their anxiety symptoms. During ICC sessions, youth see word-sentence pairs and are required to indicate whether word and sentence are related, but are not provided with feedback that aims to "train" a reduction in interpretation bias.

Outcomes

Primary Outcome Measures

Change in linguistic interpretation bias as assessed by the word-sentence association paradigm for youth (WSAP-Y)
The WSAP-Y is a computerized assessment of interpretation bias in which youth indicate whether word-sentence pairings are related. This measure provides information about the degree to which youth evidence interpretation bias, as well as a behavioral (reaction time) index for bias endorsement.
Change in visual interpretation bias as assessed by the ambiguous faces task
Youth view faces portraying neutral expressions or subtle emotional expressions (i.e., morphed faces ranging in intensity of emotional valence). Youth categorization of faces as neutral or threatening provides their sensitivity and bias for reporting presence of threat.
Change in self-reported interpretation bias as measured by the Children's Automatic Thoughts Scale (CATS)
The Children's Automatic Thoughts Scale is a youth self-report questionnaire which assesses presence and frequency of a variety of anxious thoughts from domains of: physical threat, social threat, personal failure, and anxious hostility. Total scores range from 0 to 160, with higher scores indicating more threat interpretations (i.e., worse score).

Secondary Outcome Measures

Feasibility of CBM-I: Proportion of CBM-I trainings completed of 16 intended sessions.
Proportion of CBM-I trainings completed of 16 intended sessions.
Participant/Parent Acceptability Questionnaire (PAQ)
The Participant Acceptability Questionnaire is a 10-item youth and parent report questionnaire, accompanied by an exit interview, that assesses burden (travel, boredom), credibility of computerized intervention techniques, and youth comprehension of the intervention.

Full Information

First Posted
January 12, 2020
Last Updated
February 16, 2023
Sponsor
University of Denver
Collaborators
National Institute of Mental Health (NIMH), University of California, Los Angeles
search

1. Study Identification

Unique Protocol Identification Number
NCT04245501
Brief Title
Threat Interpretation Bias as Cognitive Marker and Treatment Target in Pediatric Anxiety
Official Title
Threat Interpretation Bias as Cognitive Marker and Treatment Target in Pediatric Anxiety
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Completed
Study Start Date
June 20, 2020 (Actual)
Primary Completion Date
November 15, 2022 (Actual)
Study Completion Date
November 15, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Denver
Collaborators
National Institute of Mental Health (NIMH), University of California, Los Angeles

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Anxiety is the most common mental health problem in children and adolescents. This two-phased study will test the effects of an experimental computerized intervention aimed at reducing threat-based thinking (i.e., interpretation bias) in anxious youth. Participants in both the R61 (N=46) and R33 (N=72) trials will be youth ages 10 to 17 with a primary anxiety disorder (Separation, Social, Generalized). In the R61 trial, youth will be randomly assigned to receive 16 sessions over 4 weeks of either a personalized cognitive bias modification program for interpretation bias (CBM-I) or a computerized control condition (ICC). If CBM-I reduces interpretation bias significantly more than the ICC, the R33 trial will commence. In the R33, youth will be randomly assigned to either CBM-I or an equal amount of time in a cognitive restructuring intervention, which also aims to reduce threat-based thinking in anxiety.
Detailed Description
Anxiety is the most common mental health problem in youth, affecting one in four children and adolescents. Unfortunately, evidence-based treatments (pharmacotherapy, cognitive-behavioral therapy) are costly, not widely available, and ineffective for a substantial proportion of youth. In response, experts have called for novel treatments that directly target mechanisms underlying youth anxiety while simultaneously addressing barriers to care (i.e., cost, accessibility). One such promising mechanism is interpretation bias - the inaccurate interpretation of threat from ambiguity. The investigators have previously demonstrated that interpretation bias occurs in over 90% of anxious youth, is predictive of anxiety severity in clinical samples of youth, and differentiates between anxious and non-anxious youth. These data indicate that interpretation bias may be a ubiquitous phenomenon underlying anxiety expression in children and adolescents and therefore may be an ideal intervention target. Cognitive bias modification for interpretation bias (CBM-I) is a computerized intervention that attempts to reduce anxiety by directly modifying interpretation bias. CBM-I has demonstrated preliminary efficacy for reducing anxiety symptoms in adults. Yet extant CBM-I data in anxious youth are sparse, with little work addressing whether CBM-I significantly reduces interpretation bias, and whether this in turn reduces anxiety symptoms, as well as the dose necessary to reduce both bias and anxiety. This two-phased study tests personalized CBM-I in youth ages 10 to 17 who meet diagnostic criteria for a primary anxiety disorder (Separation, Social, Generalized). In the R61 Phase (N=46), a randomized clinical trial (RCT) examines whether CBM-I personalized to youth anxiety symptoms significantly reduces interpretation bias compared to a computerized interpretation control condition (ICC). The interpretation target will be measured at multiple time points (4, 8, 12, 16 sessions) to identify the optimal dose for reduction in interpretation bias. If the R61 trial results indicate that CBM-I outperforms ICC on interpretation bias reduction, the R33 phase will commence. In the R33 Phase, an RCT (N=72) will validate whether CBM-I significantly reduces interpretation bias, and conducts a mechanism test (i.e., does bias reduction precede and predict anxiety reduction?), by comparing CBM-I to cognitive restructuring, a clinically relevant psychosocial intervention that also targets anxious cognition.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anxiety Disorders
Keywords
Child, Adolescent, Pediatric, Youth, Anxiety, Separation anxiety, Social phobia, Social anxiety, Generalized anxiety, Interpretation bias, Cognitive bias, Cognitive bias modification, Interpretation bias modification, Randomized controlled trial, Threat bias, Threat interpretation, Intervention, Randomized, Cognitive training, National Institute of Mental Health, Personalized

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Eligible youth will be randomly assigned to receive either 16 sessions of a personalized cognitive bias modification for interpretation bias (CBM-I) intervention or a computerized interpretation control condition (ICC). Regardless of randomization, participants will complete 16 sessions of their assigned condition within 4 weeks (1 in-lab training per week, and 3 at-home trainings per week).
Masking
ParticipantOutcomes Assessor
Masking Description
Both participants and outcome assessors will be blind to condition. Unblinding occurs following all post-intervention assessment (i.e., after 16 CBM-I or ICC sessions).
Allocation
Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Cognitive Bias Modification for Interpretations (CBM-I)
Arm Type
Experimental
Arm Description
Computerized 16-session intervention aimed at reducing interpretation bias. In this study, CBM-I is personalized to youth anxiety symptoms. During CBM-I sessions, youth indicate whether word-sentence pairs are related, and are provided with feedback aimed to reduce bias.
Arm Title
Interpretation Control Condition (ICC)
Arm Type
Placebo Comparator
Arm Description
Computerized 16-session intervention that is not believed to significantly modify bias. In this study, youth see stimuli personalized to their anxiety symptoms. During ICC sessions, youth see word-sentence pairs and are required to indicate whether word and sentence are related, but are not provided with feedback that aims to "train" a reduction in interpretation bias.
Intervention Type
Other
Intervention Name(s)
Cognitive Bias Modification for Interpretations (CBM-I)
Other Intervention Name(s)
Interpretation bias modification, Interpretation training
Intervention Description
Computerized intervention in which youth see word-sentence pairs personalized to their anxiety symptoms, and indicate whether these are related. Youth receive feedback aimed to reduce interpretation bias.
Intervention Type
Other
Intervention Name(s)
Interpretation Control Condition (ICC)
Intervention Description
Computerized control condition in which youth see word-sentence pairs personalized to their anxiety symptoms. Youth indicate whether these are related, but are not provided with feedback that aims to "train" a reduction in interpretation bias.
Primary Outcome Measure Information:
Title
Change in linguistic interpretation bias as assessed by the word-sentence association paradigm for youth (WSAP-Y)
Description
The WSAP-Y is a computerized assessment of interpretation bias in which youth indicate whether word-sentence pairings are related. This measure provides information about the degree to which youth evidence interpretation bias, as well as a behavioral (reaction time) index for bias endorsement.
Time Frame
baseline, 6 weeks
Title
Change in visual interpretation bias as assessed by the ambiguous faces task
Description
Youth view faces portraying neutral expressions or subtle emotional expressions (i.e., morphed faces ranging in intensity of emotional valence). Youth categorization of faces as neutral or threatening provides their sensitivity and bias for reporting presence of threat.
Time Frame
baseline, 6 weeks
Title
Change in self-reported interpretation bias as measured by the Children's Automatic Thoughts Scale (CATS)
Description
The Children's Automatic Thoughts Scale is a youth self-report questionnaire which assesses presence and frequency of a variety of anxious thoughts from domains of: physical threat, social threat, personal failure, and anxious hostility. Total scores range from 0 to 160, with higher scores indicating more threat interpretations (i.e., worse score).
Time Frame
baseline, 6 weeks
Secondary Outcome Measure Information:
Title
Feasibility of CBM-I: Proportion of CBM-I trainings completed of 16 intended sessions.
Description
Proportion of CBM-I trainings completed of 16 intended sessions.
Time Frame
baseline, 6 weeks
Title
Participant/Parent Acceptability Questionnaire (PAQ)
Description
The Participant Acceptability Questionnaire is a 10-item youth and parent report questionnaire, accompanied by an exit interview, that assesses burden (travel, boredom), credibility of computerized intervention techniques, and youth comprehension of the intervention.
Time Frame
baseline, 6 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
10 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: youth aged 10 to 17 diagnosed at study baseline with a primary "big three" anxiety disorder (Separation, Social, Generalized) standard score greater than or equal to 85 on the Wide Range Achievement Test - Word Reading Subtest (to ensure ability to read stimuli during interpretation bias assessment and CBM-I/ICC), and estimated IQ standard score of at least 80 on the Wechsler Abbreviated Scale of Intelligence youth and consenting parent/legal guardian speak sufficient English to complete consent/assent and study procedures no concurrent psychosocial services during study participation to reduce likelihood that other interventions are responsible for change in primary or secondary outcomes no psychotropic medications with no plans to start medications during study, or six weeks stable on SSRI or psychostimulant medication and dose with no plans to change medication/dose during study Exclusion Criteria: severe anxiety indicting that youth requires higher level of care (e.g., intensive treatment such as psychiatric hospitalization), significant diagnostic comorbidity (e.g., presence of psychosis or significant mood disorder), or another primary diagnosis that warrants alternate intervention significant uncorrected vision impairment (e.g., uncorrected blindness) that precludes participation in CBM-I/ICC safety concerns due to recent or acute suicidality with plan, intent, and/or attempt that warrants alternate intervention
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michelle S Rozenman, Ph.D.
Organizational Affiliation
University of Denver
Official's Role
Principal Investigator
Facility Information:
Facility Name
BRAVE Lab, Department of Psychology, University of Denver
City
Denver
State/Province
Colorado
ZIP/Postal Code
80210
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Data resulting from this project will be de-identified and uploaded in a timely manner to the National Database for Clinical Trials Related to Mental Illness, including de-identified youth demographic and clinical characteristics, and summary scores from outcome measures, along with a data dictionary that provides variable definitions, value labels, and scoring of measures. The study protocol and dataset may be made available to other investigators based on successful completion of a data request form, following the conclusion of this study and publication of primary outcome papers.
IPD Sharing Time Frame
Data will become available following conclusion of the study and publication of primary outcome papers.
IPD Sharing Access Criteria
Researchers will be required to complete a request form that includes: research identifying information and institutional affiliation, description of research objectives, and IRB approval. Completed request forms will be reviewed by the PI and Co-Is to ensure that the research request will not duplicate work being conducted by the study team. The requesting researcher must provide signed data sharing agreements from all users on their team outlining the details of how information will be kept secure, consistent with NIMH and University of Denver data sharing guidelines. Requesting researchers will also provide the University of Denver's IRB with an IRB approval from their institution. The data will only be released after the proposed study has been completed and primary outcomes have been accepted for publication.

Learn more about this trial

Threat Interpretation Bias as Cognitive Marker and Treatment Target in Pediatric Anxiety

We'll reach out to this number within 24 hrs